Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial.

Udo BavendiekAnika GroßhennigJohannes SchwabDominik BerlinerXiaofei LiuLars MaierThomas GasparAndreas RiethSebastian PhilippRainer HambrechtRalf WestenfeldThomas MünzelSebastian WinklerMartin HülsmannDirk WestermannMarja ZdravkovicRalf LichtinghagenHeiko von der LeyenSilke ZimmermannChristian VeltmannMichael BöhmStefan StörkArmin KochJohann Bauersachs

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)

, or age ≥ 75 years. In any other patient, digitoxin may be safely started at 0.07 mg o.d.

Keyphrases

heart failure
acute heart failure
case report
phase iii
electronic health record
study protocol
clinical trial
big data
phase ii
left ventricular
atrial fibrillation
cardiac resynchronization therapy
randomized controlled trial
machine learning
artificial intelligence
open label